Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors

por Ando, Yuichi, Inada-Inoue, Megumi, Mitsuma, Ayako, Yoshino, Takayuki, Ohtsu, Atsushi, Suenaga, Naoko, Sato, Masahiko, Kakizume, Tomoyuki, Robson, Matthew, Quadt, Cornelia, Doi, Toshihiko
Publicado 2014

Chemotherapy for biliary tract cancer: real-world experience in a single institute

por Maeda, Osamu, Ebata, Tomoki, Shimokata, Tomoya, Matsuoka, Ayumu, Inada-Inoue, Megumi, Morita, Sachi, Takano, Yuko, Urakawa, Hiroshi, Miyai, Yuki, Sugishita, Mihoko, Mitsuma, Ayako, Ando, Masahiko, Mizuno, Takashi, Nagino, Masato, Ando, Yuichi
Publicado 2020